Cooley advised Cellares on the fundraising. Cellares has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the...
You must be a Standard 1 Year member to access this content.
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
You must be a Standard 1 Year member to access this content.
Sidley represented Sixth Street Growth on the deal while Cooley advised Atlas. Sixth Street Growth announced its Series B strategic investment of up to US$200 million in...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
You must be a Standard 1 Year member to access this content.
